How to democratize access and prevent the next supermodel medicine
IHS Markit | Life Sciences Research and Analysis
by
2y ago
..read more
Visit website
United States experience dramatic shift in public share of healthcare spending
IHS Markit | Life Sciences Research and Analysis
by
2y ago
..read more
Visit website
Norwegian pharma industry calls for tendering and IRP reforms
IHS Markit | Life Sciences Research and Analysis
by
2y ago
..read more
Visit website
Greek pharma industry unites against growing burden of clawback
IHS Markit | Life Sciences Research and Analysis
by
2y ago
..read more
Visit website
An all encompassing market access strategy in Africa?
IHS Markit | Life Sciences Research and Analysis
by
2y ago
..read more
Visit website
Impact of the Tianjin explosion on the global pharmaceutical industry
IHS Markit | Life Sciences Research and Analysis
by
2y ago
..read more
Visit website
When do price changes occur for branded pharmaceuticals in the top 5 EU markets?
IHS Markit | Life Sciences Research and Analysis
by
2y ago
..read more
Visit website
Repatha versus Praluent: Will the approval of PCSK9 inhibitors trigger a new price war in the US?
IHS Markit | Life Sciences Research and Analysis
by
2y ago
..read more
Visit website
The economics of Ebola vaccine production
IHS Markit | Life Sciences Research and Analysis
by
2y ago
..read more
Visit website
Therapeutic positioning reports in Spain: More doubts and questions
IHS Markit | Life Sciences Research and Analysis
by
2y ago
..read more
Visit website

Follow IHS Markit | Life Sciences Research and Analysis on FeedSpot

Continue with Google
Continue with Apple
OR